Lymphangiogenic Gene Therapy With Minimal Blood Vascular Side Effects

Recent work from many laboratories has demonstrated that the vascular endothelial growth factor-C/VEGF-D/VEGFR-3 signaling pathway is crucial for lymphangiogenesis, and that mutations of the Vegfr3 gene are associated with hereditary lymphedema. Furthermore, VEGF-C gene transfer to the skin of mice...

Descripción completa

Detalles Bibliográficos
Autores principales: Saaristo, Anne, Veikkola, Tanja, Tammela, Tuomas, Enholm, Berndt, Karkkainen, Marika J., Pajusola, Katri, Bueler, Hansruedi, Ylä-Herttuala, Seppo, Alitalo, Kari
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2002
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194057/
https://www.ncbi.nlm.nih.gov/pubmed/12235206
http://dx.doi.org/10.1084/jem.20020587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194057/
https://www.ncbi.nlm.nih.gov/pubmed/12235206
http://dx.doi.org/10.1084/jem.20020587

Ejemplares similares